2002
DOI: 10.1017/s0012162201003036
|View full text |Cite
|
Sign up to set email alerts
|

Infantile neuroaxonal dystrophy (Seitelberger's disease)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
12
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 27 publications
2
12
0
Order By: Relevance
“…3 In humans, a defect in a novel pantothenate kinase gene has been shown to be responsible for Hallervorden-Spatz syndrome. 2 Reports in cats 17,18 and sheep 16 with NAD also suggest a hereditary etiology. Although it was impossible to relate the 2 litters from the present article, an inherited mode of transmission should be considered for the Papillion breed.…”
mentioning
confidence: 99%
“…3 In humans, a defect in a novel pantothenate kinase gene has been shown to be responsible for Hallervorden-Spatz syndrome. 2 Reports in cats 17,18 and sheep 16 with NAD also suggest a hereditary etiology. Although it was impossible to relate the 2 litters from the present article, an inherited mode of transmission should be considered for the Papillion breed.…”
mentioning
confidence: 99%
“…Many diseases with axonal swellings have increased frequency of seizures, most prominent in Seitelberger’s disease , infantile neuroaxonal dystrophy , cerebral malaria , traumatic brain injury and Hallervorden‐Spatz Syndrome but also seen with increased frequency in Alzheimer’s disease . The principal clinical feature of NCC is seizures; however, the trigger for seizures in NCC remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Many diseases with axonal swellings have increased frequency of seizures, most prominent in Seitelberger's disease (13,34), infantile neuroaxonal dystrophy (32), Spheroids were more clearly observed using NFp than with np-NFp or pan-NFp antibody. Ubiquitin and SOD1 in sham sections were restricted to the cytoplasm as expected.…”
Section: Discussionmentioning
confidence: 99%
“…Symptoms from INAD typically manifest themselves during early childhood, between 6 months and 3 years of age. Disease progression is rapid, resulting in severe spasticity that impairs normal movement and results in cogni-tive decline, visual impairment, and ultimately death (15,16). A major pathologic feature of INAD is the appearance of abnormal nerve endings in both the central and peripheral nervous systems.…”
mentioning
confidence: 99%